Compare NRIX & GLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRIX | GLP |
|---|---|---|
| Founded | 2009 | 2005 |
| Country | United States | United States |
| Employees | N/A | 4700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2020 | N/A |
| Metric | NRIX | GLP |
|---|---|---|
| Price | $17.50 | $46.00 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 1 |
| Target Price | $30.50 | ★ $46.00 |
| AVG Volume (30 Days) | ★ 1.2M | 36.2K |
| Earning Date | 04-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 6.72% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $76,987,000.00 | N/A |
| Revenue This Year | N/A | $64.13 |
| Revenue Next Year | $40.12 | $11.74 |
| P/E Ratio | ★ N/A | $23.28 |
| Revenue Growth | ★ 99.31 | N/A |
| 52 Week Low | $8.20 | $39.58 |
| 52 Week High | $22.50 | $56.51 |
| Indicator | NRIX | GLP |
|---|---|---|
| Relative Strength Index (RSI) | 64.82 | 49.61 |
| Support Level | $16.81 | $45.78 |
| Resistance Level | $19.98 | $48.48 |
| Average True Range (ATR) | 0.92 | 1.93 |
| MACD | 0.23 | 0.11 |
| Stochastic Oscillator | 96.64 | 70.93 |
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the GDSO segment.